TNFRSF8 and neoplasm: Another study targeted CD30 througha [89Zr]desferrioxamine (DFO)-labeled CD30-specific AC-10 antibody, which seemed a sensitive PET agent with high tumor-to-normal-tissue contrast for CD30 expression measurementand a promising radiotracer for clinical translation in patients with various lymphomas [32].